IRAKIMID

Welcome to the Brand page for “IRAKIMID”, which is offered here for Pharmaceutical and medical preparations for the treatment of oncology, autoimmune, immune-oncology and other related diseases; pharmaceutical and medical therapeutics for the treatment of oncology, autoimmune, immune-oncology and other related diseases; diagnostic reagents for the treatment of oncology, autoimmune, immune-oncology and other related diseases;.

Its status is currently believed to be active. Its class is unavailable. “IRAKIMID” is believed to be currently owned by “Kymera Therapeutics, Inc.”